Partnerships built for real delivery and long-term results. Execution that keeps priorities clear and performance predictable.
Mission & Vision
Sona-Exim, part of Sona Group, bring science closer to people through trusted pharmaceutical solutions — for healthier, better lives for patients.
To be the partner of choice for bringing global pharmaceutical innovation to patients across complex markets.
Sona Group was founded in Kyiv in 2004 as a privately owned company and quickly became an exclusive partner for international pharmaceutical manufacturers. From the very beginning, we have operated a full-cycle model — from market analysis and registration to pharmacovigilance, quality, promotion, and sales. Our growth has been consistent: new markets, stronger partnerships, and higher operational standards. Today, Sona Group operates through Sona-Pharm and Sona-Exim, with a long-term target of €100M in turnover by 2028.
Our presence spans multiple regions, supported by coordinated operations. This structure allows us to maintain continuity and efficiency across markets.
Years of experience
Brands in the company's portfolio
International manufacturing partners
Therapeutic areas
Employees
A multidisciplinary group of experts united by one standard of responsibility. Focused on long-term value, reliable execution, and partnerships built on trust.
Regional Director of Sona-Exim
He has over 15 years of experience in the pharmaceutical industry, including leadership roles in international pharmaceutical companies.
Denis focuses on disciplined partner execution and building teams that deliver reliable results in complex, regulated markets.
Information on the terms of concluding agreements with license holders for the sale of medicinal products, as well as on the acceptance, review, and fulfillment of applications for the purchase of medicinal products
(according to the Commercial Policy of LLC “Sona-Pharmexim”, Ukraine)
1. Terms of concluding agreements
1.1. LLC “Sona-Pharmexim” (hereinafter also referred to as the Company) operates in accordance with the legislation of Ukraine and the Company’s Commercial Policy. The procedure for concluding agreements with distributors and the procedure for placing orders are regulated by the Commercial Policy.
1.2. Procedure for concluding agreements
After the successful qualification of the Buyer, LLC “Sona-Pharmexim” conducts the procedure for agreeing on and signing a Supply Agreement.
The Company uses its own Agreement template with Appendices for all Buyers. Agreements for different categories of Buyers may differ but are unified within each specific category of Buyers.
The Company provides the Buyer with the agreement template for review using electronic communication tools in Word format. The Buyer adds comments and corrections in track changes mode and returns the document to LLC “Sona-Pharmexim” for approval. The changes must not violate the essential terms of the Agreement or legislative requirements.
After the Agreement text is approved by the parties, the Agreement is signed physically or using an electronic digital signature in two copies, with each party retaining one copy.
The Company reserves the right to refuse to sign the Agreement if the Buyer requires changes to the essential terms of the Agreement or does not approve the text of the Agreement within two months.
After signing the Agreement, all amendments may be made in writing by concluding Additional Agreements.
The Company may revise the terms of the Agreement if necessary, notifying its Buyers and formalizing the changes through an Additional Agreement or by signing a new Agreement.
The Agreement is valid for one year with the possibility of automatic renewal. The Company has the right to terminate the Agreement unilaterally under the conditions specified in the Agreement, notifying the Buyer in writing according to the Agreement terms.
2. Terms for acceptance, review, and fulfillment of applications for the purchase of medicinal products
2.1. LLC “SONA-PHARMEXIM” supplies Pharmaceutical Products on equal terms to all Buyers in the Distributor category (including sales to other business entities related to them through control relationships).
2.2. LLC “SONA-PHARMEXIM” supplies Pharmaceutical Products based on agreed orders from the Buyer for the supply of Pharmaceutical Products (hereinafter referred to as the “Order”).
The volume of sales of Pharmaceutical Products is distributed among Buyers in the Distributor category according to the principle of priority provision of 20% of the net income from the sale of Pharmaceutical Products for the previous calendar year (hereinafter referred to as the Quota) in accordance with Article 204 of the Law of Ukraine “On Medicinal Products” (hereinafter referred to as the Law). The Quota does not apply to Original medicinal products and medical devices.
Since the Buyer independently chooses the terms of cooperation (purchase volumes for original medicinal products and medical devices, coverage, payment terms), the Company collects the relevant information in writing from each Buyer before each quarter by the 20th day of the month preceding the start of the quarter to plan its shipments.
2.3. For regular monthly monitoring and compliance with the Quota rules, the Company collects orders from all Buyers in the Distributor category by the 5th day (or the nearest working day after the 5th if it falls on a weekend or holiday) via email: order@sona-pharmexim.com.
After receiving the orders, the Company:
analyzes the received orders for Pharmaceutical Products subject to quota distribution
reviews the decision on supplying Pharmaceutical Products taking into account:
the level of quota usage by each Buyer
the current stock of Pharmaceutical Products subject to quota at the Company’s warehouse
the order of quota utilization by Buyers
the level of order coverage by Buyers for purchasing the entire volume of Pharmaceutical Products subject to quota
the level of stock at Buyers’ warehouses
Based on the results of the analysis and review, the Company decides on the possibility of shipping volumes to certain Buyers exceeding the 20 percent specified in the Law, if necessary and in accordance with the submitted orders and relevant restrictions.
In case of a limited quantity of Pharmaceutical Products subject to quota distribution, priority is given to:
Buyers who have not yet exhausted their Quota
Orders submitted within the timeframe established by the Company
Buyers who have exhausted their Quota may receive a new order only if other Buyers have not ensured through their applications the purchase of the entire volume of finished Pharmaceutical Products subject to quota.
The Company reserves the right to refuse acceptance of an Order from the Buyer and the allocation of Pharmaceutical Products under the quota if the Order is submitted in violation of the established deadlines.
2.4. Delivery (shipment) of orders placed within the established deadlines may be carried out during the month in accordance with the schedule of planned orders of Buyers, taking into account the current terms of supply agreements.
Taking into account the above criteria, the Company confirms Buyers’ Orders by the 8th day (or the nearest working day after the 8th if it falls on a weekend or holiday) in writing from the email address order@sona-pharmexim.com. An Order confirmed in writing is considered accepted and fulfilled by the Company.
2.5. The minimum quantity of Pharmaceutical Products ordered in an Order cannot be less than the factory packaging unless otherwise agreed separately based on business feasibility.